Literature DB >> 23802663

Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Christy M Kelley1, Brian E Powers, Ramon Velazquez, Jessica A Ash, Stephen D Ginsberg, Barbara J Strupp, Elliott J Mufson.   

Abstract

In the Down syndrome (DS) population, there is an early incidence of dementia and neuropathology similar to that seen in sporadic Alzheimer's disease (AD), including dysfunction of the basal forebrain cholinergic neuron (BFCN) system. Using Ts65Dn mice, a model of DS and AD, we examined differences in the BFCN system between male and female segmentally trisomic (Ts65Dn) and disomic (2N) mice at ages 5-8 months. Quantitative stereology was applied to BFCN subfields immunolabeled for choline acetyltransferase (ChAT) within the medial septum/vertical limb of the diagonal band (MS/VDB), horizontal limb of the diagonal band (HDB) and nucleus basalis of Meynert/substantia innominata (NBM/SI). We found no sex differences in neuron number or subregion area measurement in the MS/VDB or HDB. However, 2N and Ts65Dn females showed an average 34% decrease in BFCN number and an average 20% smaller NBM/SI region area compared with genotype-matched males. Further, relative to genotype-matched males, female mice had smaller BFCNs in all subregions. These findings demonstrate that differences between the sexes in BFCNs of young adult Ts65Dn and 2N mice are region and genotype specific. In addition, changes in post-processing tissue thickness suggest altered parenchymal characteristics between male and female Ts65Dn mice.
© 2013 International Society of Neuropathology.

Entities:  

Keywords:  Down syndrome; basal forebrain; cholinergic; female; male; stereology

Mesh:

Substances:

Year:  2013        PMID: 23802663      PMCID: PMC4220609          DOI: 10.1111/bpa.12073

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  101 in total

Review 1.  Epidemiology of Down syndrome.

Authors:  Stephanie L Sherman; Emily G Allen; Lora H Bean; Sallie B Freeman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2007

Review 2.  Clinically relevant basic science studies of gender differences and sex hormone effects.

Authors:  B S McEwen; S E Alves; K Bulloch; N G Weiland
Journal:  Psychopharmacol Bull       Date:  1998

3.  Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.

Authors:  M T Davisson; C Schmidt; E C Akeson
Journal:  Prog Clin Biol Res       Date:  1990

4.  Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.

Authors:  Ann-Charlotte E Granholm; Kerstin A Ford; Lynn A Hyde; Heather A Bimonte; Christopher L Hunter; Matt Nelson; David Albeck; Linda A Sanders; Elliott J Mufson; Linda S Crnic
Journal:  Physiol Behav       Date:  2002-11

5.  Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome.

Authors:  Lee S Stewart; Michael A Persinger; Miguel A Cortez; O Carter Snead
Journal:  Behav Genet       Date:  2006-12-05       Impact factor: 2.805

Review 6.  Down syndrome.

Authors:  A Hayes; M L Batshaw
Journal:  Pediatr Clin North Am       Date:  1993-06       Impact factor: 3.278

7.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

8.  Sex differences in striatal dopamine release in healthy adults.

Authors:  Cynthia A Munro; Mary E McCaul; Dean F Wong; Lynn M Oswald; Yun Zhou; James Brasic; Hiroto Kuwabara; Anil Kumar; Mohab Alexander; Weiguo Ye; Gary S Wand
Journal:  Biol Psychiatry       Date:  2006-04-17       Impact factor: 13.382

9.  A mouse model for Down syndrome exhibits learning and behaviour deficits.

Authors:  R H Reeves; N G Irving; T H Moran; A Wohn; C Kitt; S S Sisodia; C Schmidt; R T Bronson; M T Davisson
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

10.  Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.

Authors:  Ann-Charlotte Granholm; Linda Sanders; Hyemyung Seo; Ling Lin; Kerstin Ford; Ole Isacson
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

View more
  30 in total

1.  Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.

Authors:  Brian E Powers; Ramon Velazquez; Christy M Kelley; Jessica A Ash; Myla S Strawderman; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Brain Struct Funct       Date:  2015-12-30       Impact factor: 3.270

2.  Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

3.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

4.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

5.  Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.

Authors:  Barbara J Strupp; Brian E Powers; Ramon Velazquez; Jessica A Ash; Christy M Kelley; Melissa J Alldred; Myla Strawderman; Marie A Caudill; Elliott J Mufson; Stephen D Ginsberg
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

6.  Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Jessica A Ash; Brian E Powers; Ramon Velazquez; Melissa J Alldred; Milos D Ikonomovic; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 7.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

8.  CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  Hippocampus       Date:  2018-02-12       Impact factor: 3.899

9.  Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.

Authors:  Jessica A Ash; Ramon Velazquez; Christy M Kelley; Brian E Powers; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Neurobiol Dis       Date:  2014-06-14       Impact factor: 5.996

10.  Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice.

Authors:  Jian Yan; Stephen D Ginsberg; Brian Powers; Melissa J Alldred; Arthur Saltzman; Barbara J Strupp; Marie A Caudill
Journal:  FASEB J       Date:  2014-06-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.